Search Results - Sheng, Zengmei

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Rh‐endostatin plus camrelizumab and chemotherapy in first‐line treatment of advanced non‐small cell lung cancer: A multicenter retrospective study

    Rh‐endostatin plus camrelizumab and chemotherapy in first‐line treatment of advanced non‐small cell lung cancer: A multicenter retrospective study by Pu, Xingxiang, Wang, QianZhi, Liu, Liyu, Chen, Bolin, Li, Kang, Zhou, Yu, Sheng, Zengmei, Liu, Ping, Tang, Yucheng, Xu, Li, Li, Jia, Kong, Yi, Xu, Fang, Xu, Yan, Wu, Lin

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Efficacy and Safety of Beceltinib Capsules in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia: A Multicenter, Randomized, Open-Label, Phase 1/2 Study

    Efficacy and Safety of Beceltinib Capsules in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia: A Multicenter, Randomized, Open-Label, Phase 1/2 Study by Zhou, Hu, Song, Xuewen, Sheng, Zengmei, Zhang, Feng, Wu, Guocai, Zhao, Lidong, Zhou, ZePing, Shou, Lihong, Chen, Lili, Wang, Xiaotao, Huang, Jian, Fu, Rong, Chen, Dan, Huang, Ruibin, Jiao, Zongjiu, Lu, Jian, Ruan, Yajun, Jiao, Yu

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    A Novel JAK2 Inhibitor OB756 in Treatment of Janus Kinase Inhibitor-Naive Patients with Myelofibrosis: A Phase 1/2, Open-Label, Multicenter Study

    A Novel JAK2 Inhibitor OB756 in Treatment of Janus Kinase Inhibitor-Naive Patients with Myelofibrosis: A Phase 1/2, Open-Label, Multicenter Study by Zhou, Yile, Huang, Jian, Wen, Bingbing, Zhou, Hu, Yang, Wei, Fan, Lianlian, Gong, Tiejun, Gao, Sujun, Jiao, Zongjiu, Liu, Qingchi, Zhao, Lidong, Wu, Guocai, Wu, Cuicui, Wang, Jun, Zhang, Jin, Fu, Jiaping, Sheng, Zengmei, Zhu, Zunmin, Lu, Jian, Zhang, Yi, Jin, Jie

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: